Exchange traded funds have become popular among investors but how do they differ from crowd-pleasing index funds?Index funds and ETFs offer a diversified pool of assets, giving investors access to stocks and bonds and potentially other markets. In both an index fund and an ETF, the investor has a straightforward strategy that tracks the breadth of the market by buying shares […]
The dark veil around China is creating a little too much uncertainty for investors, with the usual fear mongers piling on and sending the vast buy-the-dip crowd running for the sidelines until the smoke clears. Furthermore, Sabrient’s fundamentals-based SectorCast rankings have been flashing near-term defensive signals. The end result is a long overdue capitulation event that has left no market […]
Android: Most brokerages charge you every time you buy or sell a stock or ETF. Robinhood, however, lets you trade for free and is at last available now for Android users, as well as those on iOS.In addition to charging $US0 commissions on trades of US-listed securities, the mobile app also has features like seeing your portfolio and personal watchlist […]
Android: Most brokerages charge you every time you buy or sell a stock or ETF. Robinhood, however, lets you trade for free and is at last available now for Android users, as well as those on iOS.In addition to charging $0 commissions on trades of US-listed securities, the mobile app also has features like seeing your portfolio and personal watchlist […]
By Ben LevisohnInvestors love biotech stocks, but heading into July, Amgen (AMGN) was unloved, especially compared to its other biotech giants like Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD) and Biogen (BIIB). No longer. Shares of Amgen have jumped nearly 6% after reporting better than forecast earnings and raising its guidance. UBS analyst Matthew Roden has the details:
Amgen reported another strong […]
Tweet
Tweet
Some Long-Term Charts At Key Inflection PointsBe aware of these surroundings, friends!by Chris Kimble.It could pay to be “aware of these surroundings!”(1) – Nasdaq Composite Index (COMP) is back at 2000 highs, with little wiggle room at the top of this rising wedge pattern(2) – Google (GOOG) (GOOGL) shot up after earnings two weeks ago hitting a resistance line based […]
By Steve SearsGoldman Sachs is telling clients to hedge the bio-technology sector in anticipation of a sharp decline. Early Monday, the bank told clients to buy SPDR S&P Biotech ETF (XBI) December $230 puts. During the pre-market, the ETF was priced at $255, and the put was at $15.50.
SSPL via Getty Images
“These puts are about 10% out-of-the-money and cost about […]
By Ben LevisohnUBS analyst Mathhew Roden and team still like biotech stocks, but think it’s time to get more selective, recommending “high quality risk reward names” like Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX), while downgrading Amgen (AMGN) and Regeneron Pharmaceuticals (REGN). They explain why:
Freya Ingrid Morales/Bloomberg News
Although we still think that biotech will continue to outperform the broader markets […]
Of course, all eyes have been on Greece in an ongoing saga that, although critical to the Greeks, is mostly just an annoying distraction for global investors — partly because it has been going on for so many years, with the proverbial can of inevitability continually being kicked down the road, and partly because there can be no winners in […]
Jonathan Garber
Jun. 29, 2015, 7:17 AM
848
Greece’s Athens Stock Exchange General Index is closed until at least July 6 as markets await the outcome of Greece’s referendum, but that has not stopped Greek stocks from crashing.The Global X FTSE Greece 20 ETF (GREK) is lower by 15% in pre-market trading on Monday. The early selling has GREK trading below the $10 level for […]
